#immunotherapy — Thursday, February 05, 2026 (2 items)
| 0 | 💬 0 |
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer.
(nejm.org)
|
New England Journal of Medicine 2026-02-05 | #clinical trial #immunotherapy #breast cancer #her2 #metastatic | |
| 0 | 💬 0 |
Sensitized mast cells for targeted drug delivery and augmented cancer immunotherapy.
(linkinghub.elsevier.com)
|
Cell 2026-02-05 | #immunity #cancer #immunotherapy #drug delivery #virotherapy |